US Patent 11833173 Th1 vaccination priming for active immunotherapy
Patent 11833173 was granted and assigned to Mirror Biologics, Inc. on December, 2023 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11833173 Th1 vaccination priming for active immunotherapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
